Loading...
Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?
BACKGROUND/AIMS: Spontaneous HBeAg seroconversion occurs frequently in the immune reactive phase in HBeAg-positive chronic hepatitis B (CHB). Therefore, observation for 3-6 months before commencing antiviral therapy is recommended in patients with alanine aminotransferase (ALT) levels that exceed tw...
Saved in:
Published in: | Clin Mol Hepatol |
---|---|
Main Authors: | , , , , , , , , |
Format: | Artigo |
Language: | Inglês |
Published: |
The Korean Association for the Study of the Liver
2014
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4278066/ https://ncbi.nlm.nih.gov/pubmed/25548741 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2014.20.4.355 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|